Guardant Health Inc. Common Stock vs Schwab US Dividend Equity ETF — how do they compare? Guardant Health Inc. Common Stock trades at $165.58 (market cap $22.58B), while Schwab US Dividend Equity ETF trades at $33.1 (market cap $108.68B). The key difference: Schwab US Dividend Equity ETF is far larger — about 4.8× Guardant Health Inc. Common Stock's market cap, and Schwab US Dividend Equity ETF is more actively traded (21,463,071 versus 2,200,599). Which is the better fit depends on your goals — on Pluang, investors hold Guardant Health Inc. Common Stock for 0 Days and Schwab US Dividend Equity ETF for 62 Days on average.
| GH | SCHD | |
|---|---|---|
Market Cap | $22.58B | $108.68B |
Volume | 2,200,599 | 21,463,071 |
Sector | Health | Broad Market / Factor |
52-Week High | $187.22 | $35.21 |
52-Week Low | $61.73 | $26.44 |
Typical Hold Time | 0 Days | 62 Days |
Enterprise Value | $23.22B | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
SCHD trades at $32.65, down 0.61% on the day, with a bearish technical signal driven by moving averages. The ETF has outperformed the S&P 500 in 2026, with dividend growth attracting income investors. Recent news highlights its defensive tilt and quality focus amid a market pullback.
Outlook is mixed: strong dividend appeal and low fees support long-term income, but technical weakness and interest rate sensitivity pose near-term risks. Investors should weigh SCHD's consistent payout growth against potential underperformance in rising rate environments.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Guardant Health develops blood tests for cancer care. Its tests support genomic profiling, cancer screening, recurrence monitoring, and treatment decisions.
Read more on GH →SCHD is an ETF that tracks the Dow Jones U.S. Dividend 100 Index. It selects high-quality companies with a consistent track record of paying dividends, focusing on financial strength metrics like cash flow to total debt and return on equity, and excluding REITs. The fund aims to provide both income and capital appreciation, making it a popular choice for long-term, dividend-focused investors.
Read more on SCHD →